Navigation Links
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
Date:3/12/2013

REDWOOD CITY, Calif., March 12, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the fourth quarter and year ended December 31, 2012, and provided a corporate update.

(Logo: http://photos.prnewswire.com/prnh/20130226/MM67303LOGO)

"We made important strides in the advancement of our sublingual Sufentanil NanoTab PCA System for the management of moderate to severe post-operative pain in 2012 and early 2013.  We announced positive results from two completed Phase 3 clinical trials, and we expect the results from our third and final planned Phase 3 trial of the NanoTab System in the second quarter of 2013," stated Richard King , President and CEO of AcelRx. Mr. King added, "In addition, in December 2012, we strengthened our balance sheet when we raised $48 million in gross proceeds, $44 million in net proceeds, through a public offering of our common stock. These funds will provide the capital needed to submit an NDA for the NanoTab System, expected in the third quarter of 2013, and to continue with commercial preparations for launch of the product in the U.S."

Fourth Quarter and Full Year Financial ResultsNet loss for the fourth quarter of 2012 was $10.5 million, or $0.41 per share, compared with a net loss of $6.4 million, or $0.33 per share, for the fourth quarter of 2011.  Common shares used in calculating basic and diluted earnings per share were 25,587,614 for the fourth quarter of 2012 compared to 19,567,778 common shares for the fourth quarter of 2011.

During the fourth quarter of 2012, Acel
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
2. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
3. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
4. AcelRx Pharmaceuticals Provides Clinical Trial Updates
5. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
6. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
7. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
8. AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
9. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
10. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
11. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based solutions ... it has commenced an underwritten public offering of its ... by Nevro and 2,459,175 shares to be sold by ... grant the underwriters a 30-day option to purchase up ...
(Date:6/1/2015)... MECHANICSBURG, Pa. , June 1, 2015 ... announced that MJ Acquisition Corporation, a joint venture that ... Stowe XII, L.P., has completed its previously announced acquisition ... in the new joint venture. About ... leading operator of specialty hospitals and outpatient rehabilitation clinics ...
(Date:6/1/2015)... 1, 2015 NEOVIA ONCOLOGY Ltd. ... the development and commercialization of novel, multi-function drugs ... met with the U.S. Food and Drug Administration ... an Investigational New Drug (IND) application for its ... of the meeting, Neovia has clarified details of ...
Breaking Medicine Technology:Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3Neovia Oncology Announces First IND Meeting 2
... 2012  Delcath Systems, Inc. (NASDAQ: DCTH ) ... initial launch and training agreement for the Delcath Hepatic ... Roussy ("IGR"), a leading European cancer center located in ... Company will provide the IGR with logistics and clinical ...
... March 15, 2012 LifeSecure Insurance Company ... shop where caregivers can access quality home care products ... loved ones. LifeSecure,s Caregiver,s Marketplace offers ... aids and home modification tools to medical supplies. It ...
Cached Medicine Technology:Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France 2Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France 3Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France 4LifeSecure Opens Online Caregiver's Marketplace 2
(Date:6/2/2015)... Atlantic Spine Center , a ... three locations in New Jersey, announces the opening of ... facility is at 1045 Park Avenue (at East 86th ... can be arranged by calling 1-844-912-2406. , Dr. ... Center, has been a pioneer in the development of ...
(Date:6/2/2015)... June 02, 2015 SB 277 (CA ... for children to attend public or private school. SB277 ... but bypassed the Appropriations Committee (Sacramento Bee, May 11, ... contentious hearings. , “We believe that this bill ... (PBEs) more than it will (the) affect public health ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Specialty ... audit, compliance and risk solutions , and Radar ... risk management effectiveness gap-improvement program. , All organizations ... uncertainty on objectives. Organizations not only assess and ... capabilities to do this (risk managing) thereby embedding ...
(Date:6/1/2015)... The National Association of Professional ... a 2015-2016 inductee into its VIP Woman of the ... for leadership in business. NAPW is the nation’s leading ... 700,000 members and over 200 operating Local Chapters. , ... said NAPW President Star Jones. “Job satisfaction is essential ...
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Woman of the Year ... leadership in life coaching. NAPW is the nation’s leading ... 700,000 members and over 200 operating Local Chapters. , ... said NAPW President Star Jones. “Her work as a ...
Breaking Medicine News(10 mins):Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2
... Pharmacologic Data Presented at American Association for Cancer Research,s ... DENVER, April 21 Poniard Pharmaceuticals, Inc. (Nasdaq: ... today announced the presentation of final data from a ... picoplatin in patients with solid tumors. Results showed that ...
... April 21 Bio-Optronics, Inc. will enhance ... with click-through integration to Interspond,s RxPaying(TM) debit ... payment alternative which improves efficiency and increases ... points in clinical trial workflow into which ...
... Scenic ride and summer weekend fun ahead in Gladstone GLADSTONE, ... Cross is teaming up with several area groups and businesses to ... with the first annual "Da, U.P. Ride for the Red" on ... Friday, July 17, local food vendors will offer their fares. Beer ...
... clopidogrel can be prescribed to patients with acute ischaemia ... (ASA). The Institute for Quality and Efficiency in Health ... clopidogrel and ASA actually has a higher benefit for ... published on 31 March 2009, concludes that combination therapy ...
... April 21 More people are turning to ... their medical condition - tattooing. A case ... the American Association of Clinical Endocrinologists (AACE) 18th ... this new phenomenon, while urging discussion from the ...
... 21 Hill-Rom Holdings, Inc.,s, (NYSE: HRC ) fiscal ... 2009. You are invited to participate in a webcast the ... Earnings Release: Hill-Rom Holdings, Inc.,s Fiscal 2009 Second ... released to the public after the NYSE close on Monday, May ...
Cached Medicine News:Health News:Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability 2Health News:Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability 3Health News:Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability 4Health News:Bio-Optronics Incorporates RxPaying(TM) Patient Stipend Debit Card Feature in Clinical Conductor(TM) Clinical Trial Management System (CTMS) 2Health News:ASA plus clopidogrel reduces heart attack risk in patients with acute coronary syndrome 2Health News:ASA plus clopidogrel reduces heart attack risk in patients with acute coronary syndrome 3Health News:ASA plus clopidogrel reduces heart attack risk in patients with acute coronary syndrome 4Health News:New Research Reveals Need for Doctors to Know About Medical Tattoos 2Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast 2
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
... family of 100% latex-free ... variety of options for ... catheter is made of ... and has smooth fire ...
Used for intermittent catheterization of a male or female patient to provide drainage of urine from the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... An indirect immunofluorescence antibody test ... anti-neutrophil cytoplasmic antibodies (ANCA) in human ... sera of patients with necrotizing vasculitides ... to the clinical and other laboratory ...
Medicine Products: